Mass High Tech: The Journal of New England Technology
Boston's Solace Pharmaceuticals Inc.'s co-founder, Clifford Woolf, has published a paper in the journal Nature Medicine about his discovery of a molecule linked to pain, official said.
The molecule, called BH4, is activated during painful states. And by inhibiting the human "pain gene" that produces BH4, scientists have been able to reduce pain, according to company officials.
Executives said that the findings in the paper would aid in its development of new pain treatments with limited side-effects.
Founded in March 2006 by scientists and backed by Boston tech-finance firm PureTech Ventures, which also manages the company, privately held Solace is in development of treatments for chronic pain.